Patents Assigned to Baxter Healthcare S.A.
  • Patent number: 9254279
    Abstract: Therapeutic compositions capable of removing excess nitric oxide are provided. The therapeutic compositions include nitronyl nitroxide monoradicals, B12 derivatives, flavonoid derivatives, the like and combinations thereof. The therapeutic compositions can be utilized in a number of suitable applications, such as to prevent or treat intradialytic hypotension during dialysis.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: February 9, 2016
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Sujatha Karoor, Ton That Hai, Cong Jiang, Paul Sanders, Cliff Holmes
  • Patent number: 9251310
    Abstract: A method for organizing care for a patient undergoing a peritoneal dialysis therapy under a system including at least one display device, at least one memory device, at least one processor and at least one peritoneal dialysis instrument for performing the peritoneal dialysis therapy, the method comprising: organizing information for presentation in a plurality of screens using the at least one display device, the at least one memory device, and the at least one processor, wherein each screen presents information pertinent to a particular aspect of the peritoneal dialysis therapy; and displaying in the plurality of screens information about the patient's prescription for the peritoneal dialysis therapy, information about medication the patient is taking in connection with the peritoneal dialysis therapy, and information about the patient's compliance with the peritoneal dialysis therapy.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: February 2, 2016
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Larry McNally, Andy Vecsey, Rich DeLaCruz, Salim Mujais, Like Coman, Richard Marritt, Catherine Firanek
  • Patent number: 9248215
    Abstract: The present invention relates to a biodegradable fibrin based composition for injection into osseous defects or voids, which can be the result of osteoporosis, surgery, bone cysts, tumor removal or traumatic bone injury.
    Type: Grant
    Filed: April 17, 2007
    Date of Patent: February 2, 2016
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: John J. Barry, Andreas Goessl, Heinz Gulle, Monika Mangold, Melitta Bilban
  • Patent number: 9242034
    Abstract: A dialysis system includes a dialysis machine including at least one fluid pump, and an autoconnection mechanism including a moveable holder; a plurality of pierceable connectors each held by the moveable holder of the autoconnection mechanism, each of the pierceable connectors in fluid communication with a source of medical fluid; a plurality of spikes each held fixed by the dialysis machine, each of the spikes in fluid communication with a disposable component that is positioned and arranged to operate with the at least one fluid pump; and wherein the moveable holder is moved automatically by the autoconnection mechanism, so that (i) the spikes pierce the pierceable connectors and (ii) the sources of medical fluid can communicate with the disposable component positioned and arranged to operate with the at least one fluid pump.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: January 26, 2016
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Robert W. Childers, Patrick Lee, Andrey Kopychev, Douglas Reitz, Rodolfo Roger, John F. Steck
  • Patent number: 9242035
    Abstract: A dialysis system comprising: a sorbent cartridge in fluid communication with at least one of a patient or a dialyzer, the sorbent cartridge including a housing having a zirconium phosphate layer followed by at least one of a urease layer, a zirconium oxide layer, or a carbon layer; a storage container in fluid communication with the sorbent cartridge; a pump in fluid communication sorbent cartridge and the storage container; and a control unit in operable communication with the pump, wherein the control unit is programmed to cause the pump to pump a dialysis fluid to flow (i) in a first direction through the sorbent cartridge, wherein the zirconium phosphate layer is contacted by the dialysis fluid before the at least one of the urease layer, zirconium oxide layer or carbon layer and (ii) in a second direction, reverse from the first direction, through the sorbent cartridge wherein the at least one of the urease layer, zirconium oxide layer or carbon layer is contacted by the dialysis fluid before the zircon
    Type: Grant
    Filed: January 18, 2013
    Date of Patent: January 26, 2016
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventor: Sujatha Karoor
  • Patent number: 9234850
    Abstract: A drip chamber for an infusion tube, including: a first end arranged to receive a drip tube; a second end including an exit port; at least one wall connecting the first and second ends; a space enclosed by the first and second ends and the at least one wall; and at least one lens integral to the at least one wall or directly fixed to the at least one wall.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: January 12, 2016
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Peter Hammond, James F. Munro, Luke Postema, Tuan Bui
  • Patent number: 9227003
    Abstract: A method for a hybrid blood and peritoneal dialysis (“PD”) machine comprising: (i) determining whether a previous treatment left a last fill of dialysate in a patient's peritoneum; (ii) if a next treatment is a PD treatment, and if the previous treatment did not leave the last fill of dialysate, causing a PD treatment in which a first cycle is a fill cycle to be initiated; (iii) if the next treatment is a PD treatment, and if the previous treatment did leave the last fill of dialysate, causing a PD treatment in which a first cycle is a last fill drain cycle to be initiated; and (iv) if the next treatment is a blood treatment and if the previous treatment did leave the last fill of dialysate, causing a blood treatment including a last fill drain cycle to be initiated.
    Type: Grant
    Filed: August 26, 2013
    Date of Patent: January 5, 2016
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Gino Cicchello, Christian Bernard, Robert W. Childers, Anthony Simiele
  • Patent number: 9227004
    Abstract: A peritoneal dialysis machine includes an enclosure; dialysate pump located within the enclosure; a graphical user interface allowing a patient to program a treatment including at least one patient fill performed by the dialysate pump, at least one dwell, and at least one drain performed by the dialysate pump; and the GUI further programmed to provide an alert when it is time to begin the treatment so as to complete the at least one patient fill, dwell and drain by a prescribed time.
    Type: Grant
    Filed: October 12, 2012
    Date of Patent: January 5, 2016
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: John A. Biewer, Andrey Kopychev, Merrick F. Kossack, Philip J. D'Almada Remedios
  • Patent number: 9216246
    Abstract: A renal failure therapy method includes causing therapy fluid to flow to a renal failure therapy filter, directing at least twenty-five percent of the therapy fluid to the renal failure therapy filter to perform conductive clearance, and using the renal therapy failure filter to cause at least a substantial amount of the remaining therapy fluid to perform diffusive clearance.
    Type: Grant
    Filed: September 30, 2011
    Date of Patent: December 22, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Thomas Kelly, Robert W. Childers, Don Busby, Rodolfo Roger, Waleed Mutasem El Sayyid, Shahid Din
  • Patent number: 9211370
    Abstract: A renal therapy blood cleansing system is provided. The renal therapy blood cleansing system includes a blood filtering device in fluid communication with a blood circuit, a balance chamber configured to exchange like volumes of fresh and used therapy fluid with the blood filtering device, a first pump configured to pump fresh fluid to the balance chamber, a second pump positioned and arranged to receive used fluid from the blood filtering device, and a control scheme. The control scheme is programmed to isolate the blood filtering device from the second pump and deliver a volume of fresh fluid to the blood filtering device via the balance chamber while the second pump is isolated from the blood filtering device, so as to increase fluid volume within the blood circuit.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: December 15, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Thomas D. Kelly, Waleed M. El Sayyid
  • Patent number: 9180238
    Abstract: A dialysis machine includes a control unit having a user interface; a heater(s) located separate from the control unit; a supervisory processor located with the control unit; a delegate control processor located with the heater(s), the delegate control processor in communication with the supervisory processor and configured to receive load cell, heater(s) plate and supply bag temperature sensor inputs; and a sub-delegate heater(s) processor in communication with the control processor and configured to control power to the heater(s). The machine can also include primary and secondary monitoring processors that perform a safety check to the control processing and monitor the load cell.
    Type: Grant
    Filed: June 11, 2008
    Date of Patent: November 10, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: John Bedingfield, Benjamin Kellam, Ronald D. Baerg, Gideon Hecht
  • Patent number: 9179898
    Abstract: A laparoscopic tissue sealant spray apparatus and system having a laparoscopic tissue sealant spray assembly combined with a trocar assembly, the tissue sealant spray assembly having an elongate delivery tube. A spray outlet at a distal end of the elongate delivery tube may be rounded or angled. A ring member provided at the distal end of the elongate delivery tube directs a spray cone toward a portion of a target tissue site, and the spray cone may be repositioned to a different portion of the target tissue site by rotation of the elongate delivery tube. The trocar assembly includes a vent opening that connects to a venting valve member that provides a vent path which passively opens upon operation of the tissue sealant spray assembly, avoiding excessive pressure build-up within a body cavity.
    Type: Grant
    Filed: December 30, 2009
    Date of Patent: November 10, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Heinz Redl, Zafar Khakpour, Rene Fortelny
  • Patent number: 9168325
    Abstract: The invention discloses a pharmaceutical hemostatic liquid foam base preparation comprising albumin as foaming agent and a fibrinogen precipitating substance and optionally a coagulation inducing agent, wherein albumin as foaming agent is present in native form; a method for the production of a transient hemostatic liquid foam; the transient hemostatic liquid foam; and a kit for making the foam.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: October 27, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Andreas Goessl, Katarzyna Gorna
  • Patent number: 9168333
    Abstract: A dialysis system includes a dialysis machine having a pump actuator, a valve actuator and a sorbent device, and a disposable cassette including (i) a housing having a dialyzer inlet port, a dialyzer outlet port, a pump portion configured to operate with the pump actuator, a valve portion configured to operate with the valve actuator, a venous port, and an arterial port, (ii) at least one dialyzer in fluid communication with the housing, the at least one dialyzer including a dialysate inlet, and a dialysate outlet; (iii) an arterial line for connecting to a patient, the arterial line connected to and extending externally from the arterial port of the housing; (iv) a venous line for connecting to a patient, the venous line connected to and extending externally from the venous port of the housing; and (v) first and second dialysate fluid connections in fluid communication with the sorbent device.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: October 27, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Thomas Kelly, Robert W. Childers, Don Busby, Rodolfo Roger, Waleed Mutasem El Sayyid, Shahid Din
  • Patent number: 9162006
    Abstract: The present invention provides a hemostatic porous sponge comprising a matrix of a fibrous biomaterial and particles of a fluid absorbing, particulate material adhered to said matrix material, a method of producing these sponges and their use for wound healing.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: October 20, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Joris Hoefinghoff, Hans Christian Hedrich
  • Patent number: 9162021
    Abstract: A system and method for determining a concentration of total chlorine in dialysis water are provided. The system comprises a main unit housing an iodide/water sample chamber and a reducing agent chamber. An electrode pair bridges the two chambers and generates tri-iodide proportional to the amount of total chlorine in the dialysis water. The electrode pair detects the amount of tri-iodide generated in proportion to the amount of active chloride in the dialysis water. The system is suitable for use in connection with, or for incorporation into, a water purification system for generating dialysis fluid, and may include a display that alerts the user to stop or prevent a hemodialysis treatment if the total chlorine level exceeds a predetermined level.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: October 20, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Jeff White, Ye Chen, Samuel Ding, Joel Titus, Justin Rohde, Shincy Maliekkal, Kevin Cooper
  • Patent number: 9155825
    Abstract: A hemodialysis system including (i) a dialyzer; (ii) a blood circuit including a blood pump in fluid communication with the dialyzer; (iii) a dialysate circuit including a dialysate circulation pump in fluid communication with the dialyzer, at least a portion of the dialysate circuit incorporated into a disposable dialysate cassette; (iv) a sorbent cartridge for cleaning used dialysate flowing in the dialysate circuit; (v) a reservoir holding an initial supply of dialysate; (vi) a reservoir pump in fluid communication with the dialysate circuit and the reservoir; (vii) a supply of infusate; and (viii) an infusate pump in fluid communication with the dialysate circuit and the supply of infusate.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: October 13, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Thomas Kelly, Robert W. Childers, Don Busby, Rodolfo Roger, Waleed Mutasem El Sayyid, Shahid Din
  • Patent number: 9149570
    Abstract: A peritoneal dialysis system includes a logic implementer configured to: (i) generate a number of peritoneal dialysis therapy regimens that meet at least one therapy target input; (ii) accept a filter input; and (iii) filter the generated therapy regimens according to the filter input to refine the number of therapy regimens available for selection.
    Type: Grant
    Filed: April 3, 2012
    Date of Patent: October 6, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Anping Yu, Robert W. Childers, Edward F. Vonesh, Borut Cizman, Michael Niemann
  • Patent number: 9147045
    Abstract: An ultrafiltration (“UF”) evaluation method includes: (i) determining an amount of UF removed from a patient over a first dwell time; (ii) determine an amount of UF removed from the patient over a second, different dwell time; (iii) determining an amount of UF removed from the patient over a third, different dwell time; and (iv) fitting a curve to the UF removal amounts for the first, second and third dwell time. A peritoneal dialysis therapy generation method using the curve determined according to the “UF” evaluation method to generate at least one peritoneal dialysis therapy regimen.
    Type: Grant
    Filed: July 9, 2008
    Date of Patent: September 29, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Anping Yu, Edward F. Vonesh, Benjamin Kellam, Robert W. Childers, Borut Cizman
  • Patent number: 9144644
    Abstract: An infusion pump, including: a specially programmed microprocessor; a drip chamber for connection to a source of fluid and to an output tubing; a pumping section including a plurality of fingers and a first actuator, controllable using the microprocessor, for sequentially displacing the plurality of finger to compress a first portion of the output tubing to displace fluid from the drip chamber through the output tubing; an inlet valve disposed between the drip chamber and the pumping section and arranged to compress the output tubing to restrict or block flow through the output tubing; and a second actuator, controllable using the microprocessor, for opening or closing the inlet valve independent of the displacement of the plurality of fingers; or for operating the inlet valve to control a rate of flow of fluid from the drip chamber to the portion of the output tubing.
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: September 29, 2015
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Roger L. Hungerford, Tuan Bui